Chemical Compound

2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide

CAS Registry Number 1086062-66-9
2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide 结构式
Primary record

2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide

库存
9,606 克
纯度
98.3 %
CAS
1086062-66-9

化合物标识与属性

CAS
1086062-66-9
PubChem CID
25167777
SMILES
COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F
Canonical SMILES
COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F

名称与同义词

  • Omipalisib
  • GSK2126458
  • 1086062-66-9
  • omipalisibum
  • GSK-2126458
  • Omipalisib?
  • GSK 2126458
  • GSK212
  • GSK-212
  • Omipalisib [USAN:INN]
  • OMIPALISIB [INN]
  • Omipalisib (USAN/INN)
  • RefChem:856774
  • 1X8F5A3NA0
  • GSK458
  • OMIPALISIB [USAN]
  • UNII-1X8F5A3NA0
  • cc-65
  • D03EZE
  • GSK 212
  • OMIPALISIB [WHO-DD]
  • MFCD16038929
  • C25H17F2N5O3S
  • 2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide
  • CHEBI:95093
  • MLS006011258
  • Omipalisib; GSK2126458
  • SCHEMBL623194
  • DTXSID10148604
  • GSK-458
  • GTPL8974
  • orb1307306
  • GSK 2126458; Omipalisib
  • Omipalisib (GSK2126458)
  • CHEMBL1236962
  • DTXCID0071095
  • SCHEMBL29352875
  • SCHEMBL29358168
  • EX-A003
  • GSK 458
  • SYN1126
  • 3l08
  • CGBJSGAELGCMKE-UHFFFAOYSA-N
  • GLXC-90092
  • HMS3656D09
  • GSK2126458 (GSK458)
  • AOB87781
  • BCP02252
  • ABP000103
  • BDBM50145416
  • NSC764092
  • NSC800807
  • s2658
  • ZINC43208634
  • 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide
  • AKOS015904655
  • Omipalisib (GSK2126458, GSK458)
  • CCG-264973
  • CS-0085
  • DB12703
  • FD43337
  • NSC-764092
  • NSC-800807
  • QC-7243
  • RL00368
  • SB16572
  • SDCCGSBI-0654406.P001
  • NCGC00250408-01
  • NCGC00250408-05
  • 4CA-0591
  • AC-28458
  • AK-55828
  • AN-17171
  • AS-16266
  • BC638723
  • BP-14100
  • CID:25167777
  • HY-10297
  • SC-85404
  • SMR004703011
  • SID:160778570
  • AB0033735
  • SK2126458
  • A8556
  • FT-0669061
  • NS00072582
  • SW219502-1
  • X7449
  • J3.800.935D
  • KS-00000635
  • A11035
  • A25172
  • D10718
  • GSK-2126458;GSK 2126458; Omipalisib
  • W-5626
  • 2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
  • C561454
  • 2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide
  • Benzenesulfonamide, 2,4-difluoro-N-(2-methoxy-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)-
  • BRD-K07972848-001-02-0
  • I14-17004
  • Q27088179
  • 2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzenesulfonamide
  • 2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide
  • 1-Propanone,1-[1-[(4-methoxyphenyl)methyl]-1H-pyrazol-4-yl]-
  • 2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-yl-6-quinolyl)-3-pyridyl]benzenesulfonamide
  • 2,4-difluoro-N-(2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl)benzenesulfonamide
  • N-[2-Methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide
  • Omipalisib, 98%, a highly selective and potent inhibitor of PI3K - 10MG 10mg
  • 1105039-60-8
  • 2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide
  • ZIG